Feb 8 2022 23:00
Pfizer forecasts $54 billion in revenue in 2022 from sales of its Covid vaccine and antiviral pill - Daily Mail
Pfizer is expecting to have a record year in 2022, making up to $102 billion in revenue. Its COVID-19 products like its vaccine and newly approved Paxlovid will produce much of it.